US Stock MarketDetailed Quotes

BVNRY BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD

Watchlist
  • 13.675
  • +0.675+5.19%
15min DelayTrading Aug 22 12:04 ET
3.19BMarket Cap21.78P/E (TTM)

About BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD Company

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Company Profile

SymbolBVNRY
Company NameBAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD
Founded1992
CEOMr. Paul Chaplin
MarketPink Market
Employees1379
Fiscal Year Ends12-31
AddressPhilip Heymans Alle 3
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-33-26-83-83
Websitehttp://www.bavarian-nordic.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul Chaplin
  • President and Chief Executive Officer
  • --
  • Henrik Juuel
  • Executive Vice President and Chief Financial Officer
  • --
  • Anders Gersel Pedersen, M.D.,PhD
  • Deputy Chairman of the Board
  • --
  • Luc Debruyne
  • Chairman of the Board
  • --
  • Anja Gjol
  • Director
  • --
  • Thomas Alex Bennekov
  • Director
  • --
  • Linette M Andersen
  • Director
  • --
  • Karen Merete Jensen
  • Director
  • --
  • Linette Munksgaard
  • Director
  • --
  • Dr. Frank Verwiel, M.B.A.,M.D.
  • Independent Director
  • --
  • Johan van Hoof
  • Independent Director
  • --
  • Peter Kurstein, M.B.A.
  • Independent Director
  • --
  • Heidi Hunter
  • Independent Director
  • --
  • Anne Louise Eberhard, M. Sc.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg